Why This Story Matters:
The National Drug & Alcohol Screening Association (NDASA) – which represents the drug and alcohol testing industry in the U.S. – will hold its annual NDASA Conference and Trade Show in April 2025 in Jacksonville, Florida. ClearStar – an innovator in drug, alcohol, and occupational health testing – will exhibit its next-generation ClearMD platform at the conference.
ClearStar Exhibiting ClearMD at 2025 NDASA Annual Conference & Trade Show
ClearStar – a global innovator powering white-labeled Medical Review Office (MRO) and occupational health solutions – will exhibit its next-generation ClearMD platform at the 2025 National Drug & Alcohol Screening Association (NDASA) Annual Conference & Trade Show in Jacksonville, Florida, from April 1st to April 4th, 2025. ClearStar will exhibit at Booth 218.
ClearStar has ignited the industry by announcing its groundbreaking ClearMD platform that ensures an effortless ordering experience for employers, a seamless and mobile-friendly process for candidates, and unmatched convenience and customization with drug, alcohol, and occupational health screening results. Employers gain a competitive edge with:
- Company-Specific Medical Forms: Tailored documents engineered to your organization’s demands.
- Handpicked Clinics on Demand: Elite, curated clinic options empower employers to effortlessly select the ideal fit.
- An End to Invoice Frustrations: Simple, upfront pricing with no unexpected charges.
ClearStar’s ClearMD platform is rapidly gaining adoption, capitalizing on a market seeking disruptive innovation. ClearMD streamlines the ordering experience for employers and delivers a modern, mobile, and user-friendly interface for candidates. Backed up by ClearStar’s relentless commitment to excellence, ClearMD seamlessly delivers compliant, exact results.
ClearStar will be represented at the conference by President of Medical Information Services Todd Shoulberg, who provides direction and leadership to the daily operations of ClearStar’s Medical Review Office. Contact Todd at [email protected] to discover how ClearStar can enhance and streamline white-labeled drug and occupational health services.
The 2025 NDASA Annual Conference & Trade Show – which will be held at the Hyatt Regency Jacksonville Riverfront in Jacksonville, Florida – “offers unparalleled opportunities for professional growth, featuring expert-led training sessions, insights from nationally renowned speakers, and dynamic networking events,” the website for the conference states.
The diverse membership of the National Drug & Alcohol Screening Association (NDASA) – the voice of the nation’s drug and alcohol screening industry – “includes testing companies, employers, laboratories, Third Party Administrators, human resources managers, safety professionals, substance abuse counselors, and others,” according to its website.
ClearStar Offers Drug, Alcohol & Occupational Health Testing with ClearMD
ClearStar – a global background screening provider that specializes in drug and alcohol testing and occupational health services – offers a fully automated electronic registration for drug tests, clinical services, and occupational health screening with ClearMD. In addition to providing testing at over 20,000 locations in the United States, ClearStar offers:
- Single candidate invite for all services via text or email
- Electronic Custody and Control Form (eCCF) available for drug and clinical tests
- Mobile wallet pass with built-in reminders available
- Real-time collection status updates
- In-house Medical Review Officer (MRO) provides doctor-reviewed results via email, fax, web, or XML
- Full integration with most Applicant Tracking Systems (ATSs)
ClearStar knows a drug-free workplace can improve safety, reduce injuries, lower costs, increase productivity, and deter employees from using drugs at work. To help employers comply with drug testing laws nationwide, ClearStar offers Drug Screening Compliance Packages, a Marijuana Legality Interactive Map, and a State Drug Testing Laws Interactive Map.
ClearStar has provided background screening solutions from its corporate offices in Alpharetta, Georgia, since 1995, and is celebrating the company’s 30th anniversary in 2025. ClearStar also offers an extensive library of On-Demand Drug Testing Webinars to help employers maintain a drug-free workplace. To learn more, contact ClearStar or visit ClearStar at Booth 218.
© 2025 ClearStar. All rights reserved. – Making copies of or using any part of the ClearStar website for any purpose is prohibited unless written authorization is first obtained from ClearStar. ClearStar does not provide or offer legal services or legal advice of any kind or nature. Any information on this website is for educational purposes only.
Let's start a conversation
Thomas Ahearn - Digital Content Editor
Thomas Ahearn is a Digital Content Editor at ClearStar, a leading Human Resources technology company specializing in background checks, drug testing, and occupational health screening. He writes about a variety of topics in the background screening industry including Artificial Intelligence (AI), "Ban the Box," class action lawsuits, credit reports, criminal records, drug testing, Equal Employment Opportunity Commission (EEOC), Fair Credit Reporting Act (FCRA), identity theft, privacy, social media screening, and workplace violence.
At ClearStar, we are committed to your success. An important part of your employment screening program involves compliance with various laws and regulations, which is why we are providing information regarding screening requirements in certain countries, region, etc. While we are happy to provide you with this information, it is your responsibility to comply with applicable laws and to understand how such information pertains to your employment screening program. The foregoing information is not offered as legal advice but is instead offered for informational purposes. ClearStar is not a law firm and does not offer legal advice and this communication does not form an attorney client relationship. The foregoing information is therefore not intended as a substitute for the legal advice of a lawyer knowledgeable of the user’s individual circumstances or to provide legal advice. ClearStar makes no assurances regarding the accuracy, completeness, or utility of the information contained in this publication. Legislative, regulatory and case law developments regularly impact on general research and this area is evolving rapidly. ClearStar expressly disclaim any warranties or responsibility or damages associated with or arising out of the information provided herein.
